The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological marker associated with the disease through a simple blood test. Apparently, that biological marker, which is found in spinal fluid, starts changing decades before the first signs of the disease show up. The problem is harvesting spinal fluid for testing is highly invasive and expensive, making it not ideal for an early detection procedure. What the IBM scientists have figured out is that it’s possible to identify the proteins in the blood that can predict the concentration of the biomarker in spinal fluid, making early detection not only possible but also affordable. The method is still in its early stages of testing, but in the future, scientists could use it to find appropriate subjects for programs developing a cure.
IBM is using machine learning to detect Alzheimer’s way before symptoms show up
More of Today's Solutions
Data centers explained: the hidden infrastructure behind your daily digital life
BY THE OPTIMIST DAILY EDITORIAL TEAM Every time you stream something, pay a bill, or ask an AI a question, a server somewhere is ...
Read MoreThree signs your garden is overheating and what to do about each one
BY THE OPTIMIST DAILY EDITORIAL TEAM It's usually around this time of the summer season when you find out which plants you’ve been taking ...
Read MoreFour surprising reasons to add more mushrooms to your diet
Here at The Optimist Daily, we are huge fans of mushrooms. As each year passes, more scientists are turning toward fantastic fungi to treat ...
Read MoreSecrets of the sea: hidden underwater forests may help fight climate crisis
The Nature Conservancy's marine biologist Frank Hurd spends his days amongst gigantic kelp curtains, studying underwater forests. One of his usual diving haunts is ...
Read More
